GNLX(GNLX)
GNLX
ANALYST COVERAGE3 analysts
BUY
▲ +447.9%upside to target
L $16.00
Med $16.00consensus
H $20.00Key MetricsTTM
Market Cap$109.84M
Revenue TTM$8.0K
Net Income TTM-$31.78M
Free Cash Flow-$27.88M
Gross Margin-3550.0%
Operating Margin-422037.5%
Net Margin-397225.0%
Return on Equity-165.2%
Return on Assets-98.2%
Debt / Equity0.11
Current Ratio3.68
EPS TTM$-0.98
PRICE
Prev Close
2.93
Open
2.90
Day Range2.87 – 2.92
2.87
2.92
52W Range2.29 – 8.54
2.29
8.54
10% of range
VOLUME & SIZE
Avg Volume
203.1K
FUNDAMENTALS
P/E Ratio
-3.4x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
TECHNICAL
RSI (14)
49
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 22
DEx-Dividend
In 90 days
Aug 19
GNLX News
About
No description available.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Yong YuChief Scientific Officer
Eric GroenGeneral Counsel, Corporate Secretary, Chief Compliance Officer & Head of Business Development
Matthew PulisicChief Financial Officer and Principal Financial & Accounting Officer
Ralph SmallingVice President & Head of Regulatory Affairs
Thomas ZindrickChairman, Chief Executive Officer & President
Jason LittenChief Medical Officer
Joseph CappelloChief Technical Officer